Marc Lustig, a Director, acquired 400,000 Common Shares on a direct ownership basis at prices ranging from $0.700 to $0.815 between March 11th, 2022 and March 14th, 2022. This represents a $291,500 investment into the company's shares and an account share holdings change of 13.6%.
PharmaCielo is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
No Comments